Share

Endocrine Society Advocates European Union Lawmakers About EDCs

On December 3-4, following the 2019 European Union (EU) elections and with the installment of the new European Commission, the Endocrine Society brought members from seven EU Member States to Brussels to meet with policy makers and urge them to take action on endocrine-disrupting chemicals (EDCs). A full day of meetings began with a briefing...
Share

Congress Takes Steps Towards Cosmetics Reform

Before Congress adjourned for the holidays, the House of Representatives was able to advance legislation that reflected some Endocrine Society priorities related to EDCs. On December 3, Rep. Frank Pallone (D-NJ) introduced the Cosmetic Safety Enhancement Act (HR 5279), which would give the U.S. Food and Drug Administration (FDA) additional authority to regulate harmful chemicals...
Share

Congress Strikes Deal for Fiscal Year 2020 Appropriations

After months of bargaining and numerous stalemates, the House of Representatives and Senate reached agreement on Fiscal Year 2020 appropriations just before funding expired on December 20. The deal also provided a “Christmas Tree” legislative vehicle for various policy measures. The spending deal was divided into two packages of individual bills covering funding for every...
Share

Endocrine Society Scientific Leaders Share Research Priorities with NIH

During November, the Endocrine Society conducted meetings with leadership at the National Institutes of Health to discuss research goals and other opportunities to partner with the institutes to advance the field. Anne Cappola, MD, ScM, and Holly Brown-Borg, PhD, met with Richard Hodes, MD, director of the National Institute on Aging (NIA); and Jennifer Richer,...